Provider review
HealthSource review
Every product on the site bills every four weeks, not monthly.
Thirteen charges a year rather than twelve — and the cadence is printed on every figure.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated August 2026
How we’re funded. Some links here are affiliate links: start care through one and we may earn a commission, at no extra cost to you. Affiliate partners are listed first on our rankings — what we write about a provider is the same either way, and unflattering findings about one that pays us stay in. Full disclosure.
Price as published
HealthSource
$199 every 4 weeks semaglutide, $299 tirzepatide
- Vs median
- Not comparable — no per-month rate is published — the verified string carries no monthly figure
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Compounded by 503A referenced
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
The four-week cycle is the whole story here, and this seller handles it about as well as a four-week cycle can be handled: the words every 4 weeks sit on the figure, on every single product, so nobody can mistake any of them for a monthly rate. That is the opposite of the usual pattern, where the cadence hides in a terms page and shows up as a thirteenth charge nobody budgeted for. What good disclosure does not change is the arithmetic. Thirteen four-week periods fit into a year rather than twelve, so every figure on this site costs roughly nine per cent more over twelve months than its face value suggests, and the gap grows with the price — on the oral tirzepatide line it runs to several hundred dollars a year. Every figure is a floor besides, with variants selected further into the product page, so the number on the card is the cheapest configuration rather than the price you will pay. No milligram appears anywhere.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You want the billing cadence on the figure rather than in the terms
- You want both injectable and oral tirzepatide from one provider
- You are comparing within one catalog priced on a consistent basis
Look elsewhere if
- You are budgeting annually — this bills thirteen times a year
- You want the card price to be the price rather than the cheapest variant
- You want a dose behind the number
What it actually costs
Price as published
NOTHING HERE IS MONTHLY. Every product carries the same cadence on its own card: tirzepatide "From: $299.00 every 4 weeks", semaglutide "From: $199.00 every 4 weeks", oral tirzepatide "From: $399.00 every 4 weeks", sermorelin "$295.00 every 4 weeks" · four weeks recurs 13.04 times a year rather than twelve, so each figure costs about 8.7% more annually than the same number would per calendar month — on the semaglutide line that is roughly $2,595 a year against $2,388 · ★ CREDIT WHERE IT IS DUE: the cadence is printed on the figure itself, on every product, rather than being buried in terms or discovered at the second charge · every price is also a floor — "From:" — with variants chosen on the product page · the 503A class is referenced once · no milligram is published
- Vs median
- Not comparable — no per-month rate is published — the verified string carries no monthly figure
- Market
- $59–$1300/mo is the full published spread in our ranking
- Structure
- Standard plan, self-directed low dose
No low-dose product of its own. Starting low means asking for a smaller amount inside a standard plan, at the standard plan's price.
152 of the 373 programs we track price a small dose this way. No low-dose product, and every figure in the catalog bills every four weeks rather than monthly — thirteen charges a year, so about 8.7% more annually than each number looks. ★ The cadence is printed on every product's own figure rather than buried, which is the best a four-week cycle can be disclosed. Every price is a floor with variants chosen further in, and no dose is published.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Not included
- Labs
- Not required
- Pricing
- Varies by dose, plan or tier
- Price last updated
- August 2026
What it does well
- Prints the four-week cadence on every product's figure rather than hiding it in terms.
- A broad catalog priced consistently on one basis.
- Both injectable and oral routes are offered for tirzepatide.
Pharmacy, labs and oversight
HealthSource dispenses through a 503A referenced facility. No bloodwork is required before you start. A clinician review is included in the price.
Transparency check
3 of 4 published openly
What HealthSource publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere we could find on its own pages.
- Published
- A price you can read before intakeA monthly rate is published on its own pages — the figure in the price row above, read there and verified against it.
- Published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
- None on file
How the program works
The four-week cycle is the whole story here, and this seller handles it about as well as a four-week cycle can be handled: the words every 4 weeks sit on the figure, on every single product, so nobody can mistake it for a monthly rate. That is the opposite of the usual pattern, where the cadence hides in a terms page and turns up as a thirteenth charge nobody budgeted for. What it does not change is the arithmetic. Thirteen four-week periods fit into a year, not twelve, so every figure on this site costs roughly nine per cent more over twelve months than its face value suggests, and the gap grows with the price — on the oral tirzepatide line it is a few hundred dollars a year. Every figure is a floor besides, with variants selected further into the product page, so the published number is the cheapest configuration rather than the price. No milligram appears anywhere.
The honest cons
Every price bills thirteen times a year, not twelve — about 8.7% more than it looks.
- Every figure is a floor, with the real price set by variants further in.
- No milligram appears against any product.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
HealthSource is one of 373 low-dose GLP-1 programs we track, and 242 of them publish a monthly rate you can read before signing up. The ranking lists every published price on one screen, ordered with the companies that pay us first — a mechanism we state there, on the page it applies to.
Where this sits
#338 of 373
Ordered with the companies that pay us first, and HealthSource is not one of them. A disclosed partition, not a score.
Compare all 373 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
- What microdosing GLP-1 costs
- Low dose vs full dose
- The true annual cost of a plan
- What a flat price costs at a low dose
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
RxSpan MD
From $194/mo
- Vs median
- $25/mo above the $169 median
- Market
- $59–$1300/mo across 242 of 373
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the RxSpan MD review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.